Quantum Biosytems of Japan, which has been developing a single-molecule electronic DNA sequencing technology that measures tunneling currents from DNA bases as the molecule passes by a sub-nanometer gap, publicly showed single-read raw sequence data for the first time this week at the Personalized Medicine World Conference in Mountain View, Calif.

Quantum is now in the midst of raising additional funding as well as awareness of its technology and plans to start an early-access program for a prototype sequencer this year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.